Drug profile · INN
nabilone
CESAMET
nabilone (CESAMET) is a cannabinoid cb1 receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — nabilone
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 6
- Data quality
- 0.84
Quick answer
nabilone (CESAMET) is a cannabinoid cb1 receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cannabinoid CB1 receptor agonist
Primary target: Cannabinoid receptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nabilone?
nabilone (CESAMET) is a cannabinoid cb1 receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nabilone?
CESAMET is a marketed brand name for nabilone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nabilone?
nabilone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.